Comment on Actavis to buy Allergan for $66 billion, topping Valeant's bid

Actavis to buy Allergan for $66 billion, topping Valeant's bid

Actavis PLC agreed to pay about $66 billion for Allergan Inc., after the maker of Botox turned to the drugmaker to repel a hostile advance from Valeant Pharmaceuticals International Inc. Actavis will pay $219 a share in cash and stock for...

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News